What questions should be asked when a patient requests a refill of acyclovir (antiviral medication) for Herpes Simplex Virus type 2 (HSV2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Key Questions for Acyclovir Refill Requests in HSV-2 Patients

When a patient requests a refill for acyclovir for HSV-2, healthcare providers should assess treatment effectiveness, adherence, and potential complications through a structured set of targeted questions about symptoms, medication use patterns, and risk factors.

Assessment of Current Treatment Regimen

  • Frequency of outbreaks/recurrences:

    • How often are you experiencing outbreaks since starting acyclovir?
    • Has there been a change in frequency compared to before treatment?
    • When was your last outbreak?
  • Current dosing regimen:

    • What dose of acyclovir are you currently taking?
    • Are you taking it for suppressive therapy (daily) or episodic treatment (only during outbreaks)?
    • If suppressive: Have you been taking it continuously for more than 1 year? 1
    • If episodic: Are you able to start medication at the first sign of prodrome or outbreak?
  • Medication effectiveness:

    • How well is the medication controlling your symptoms?
    • Has there been any change in the duration or severity of outbreaks?
    • Do you experience prodromal symptoms (tingling, burning, itching) before outbreaks?

Medication Adherence and Safety

  • Adherence assessment:

    • How often do you miss doses?
    • Do you have any difficulties taking the medication as prescribed?
    • Are you experiencing any side effects from the medication?
  • Renal function:

    • Do you have any known kidney problems?
    • Are you taking other medications that might affect kidney function? 2
    • When was your last kidney function test?
  • Hydration status:

    • Are you maintaining adequate fluid intake while on acyclovir? 2

Risk Assessment and Transmission Prevention

  • Sexual activity and protection:

    • Are you sexually active?
    • Do you abstain from sexual activity when lesions or prodromal symptoms are present?
    • Do you use condoms during sexual encounters?
    • Are you aware that HSV-2 can be transmitted even when no symptoms are present? 1
  • Partner notification:

    • Have you informed your sexual partner(s) about your HSV-2 status?
    • Has your partner(s) been tested for HSV-2?
  • For women of childbearing age:

    • Are you pregnant or planning to become pregnant?
    • Are you aware of the importance of informing healthcare providers about HSV-2 during pregnancy? 1

Complications and Special Considerations

  • Immunocompromised status:

    • Do you have HIV or any other condition affecting your immune system?
    • Have you noticed any changes in your outbreaks that seem unusual or severe? 1
  • Treatment failure indicators:

    • Are lesions persisting despite acyclovir treatment?
    • Has there been an increase in outbreak frequency despite adherence to medication?
    • For HIV-positive patients: Has your HIV treatment regimen changed recently? 1

Counseling and Education Needs

  • Understanding of condition:

    • Do you understand that acyclovir is not a cure for genital herpes? 2
    • Are you aware of the natural history of HSV-2 infection?
    • Do you need additional information about managing your condition?
  • Psychological impact:

    • How are you coping with having HSV-2?
    • Would you benefit from counseling or support resources?

Treatment Plan Reassessment

  • After 1 year of continuous suppressive therapy, consider discontinuing acyclovir temporarily to reassess the patient's rate of recurrent episodes, as the frequency of recurrences may decrease over time 1
  • For patients with frequent recurrences (≥6 per year), discuss continuing suppressive therapy versus switching to episodic treatment 1
  • For patients on suppressive therapy with very frequent recurrences (≥10 per year), ensure adequate dosing (valacyclovir 500mg once daily may be less effective than other regimens) 1

Remember that appropriate management of HSV-2 requires both effective treatment of symptoms and comprehensive counseling about preventing transmission to partners.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.